EE+ POEM Archive
Nirmatrelvir-ritonavir (Paxlovid) doesn't significantly reduce symptoms or hospitalization in vaccinated high-risk patients and unvaccinated patients
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "Nirmatrelvir-ritonavir (Paxlovid) Doesn't Significantly Reduce Symptoms or Hospitalization in Vaccinated High-risk Patients and Unvaccinated Patients." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377135/all/Nirmatrelvir_ritonavir__Paxlovid__doesn't_significantly_reduce_symptoms_or_hospitalization_in_vaccinated_high_risk_patients_and_unvaccinated_patients.
Nirmatrelvir-ritonavir (Paxlovid) doesn't significantly reduce symptoms or hospitalization in vaccinated high-risk patients and unvaccinated patients. In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377135/all/Nirmatrelvir_ritonavir__Paxlovid__doesn't_significantly_reduce_symptoms_or_hospitalization_in_vaccinated_high_risk_patients_and_unvaccinated_patients. Accessed October 5, 2024.
Nirmatrelvir-ritonavir (Paxlovid) doesn't significantly reduce symptoms or hospitalization in vaccinated high-risk patients and unvaccinated patients. (2019). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377135/all/Nirmatrelvir_ritonavir__Paxlovid__doesn't_significantly_reduce_symptoms_or_hospitalization_in_vaccinated_high_risk_patients_and_unvaccinated_patients
Nirmatrelvir-ritonavir (Paxlovid) Doesn't Significantly Reduce Symptoms or Hospitalization in Vaccinated High-risk Patients and Unvaccinated Patients [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2024 October 05]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377135/all/Nirmatrelvir_ritonavir__Paxlovid__doesn't_significantly_reduce_symptoms_or_hospitalization_in_vaccinated_high_risk_patients_and_unvaccinated_patients.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Nirmatrelvir-ritonavir (Paxlovid) doesn't significantly reduce symptoms or hospitalization in vaccinated high-risk patients and unvaccinated patients
ID - 3377135
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377135/all/Nirmatrelvir_ritonavir__Paxlovid__doesn't_significantly_reduce_symptoms_or_hospitalization_in_vaccinated_high_risk_patients_and_unvaccinated_patients
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
